nivolumab,trabectedin
valeo pharmaceutical,otsuka,pharmamar,bms
['nivolumab', 'trabectedin', 'nivo', 'sarcoma']
trabectedin + nivolumab promising in l-sarcomas. clearly, though, we need to select by more than initial letter of the histologic subtype to know who will benefit. #sarcoma #asco23 
I treat patients with sarcoma and gastrointestinal malignancies at Hospital Israelita Albert Einstein, and serve as chair of  the LACOG sarcoma group